Please provide your email address to receive an email when new articles are posted on . Outcomes for ablation of persistent AF by pulmonary vein antral isolation (PVAI) alone have been historically ...
Credit: Patrick J. Lynch, medical illustrator; C. Carl Jaffe, MD, cardiologist. Adjunctive left atrial appendage (LAA) ligation failed to increase the efficacy of catheter pulmonary vein isolation ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio The addition of left atrial appendage ...
Surgically ligating the left atrial appendage (LAA) during implantation of the HeartMate 3 left ventricular assist device (LVAD; Abbott) does not affect survival or hemocompatibility-related adverse ...
SAN FRANCISCO -- Left atrial appendage (LAA) closure might have a substantial longer-term benefit in reducing hypertension -- or it might not, as dueling studies presented opposite findings from small ...
The Nature Index 2024 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
Matthew J. Price, MD, of the Scripps Clinic (La Jolla, CA), and colleagues retrospectively studied 154 A-fib patients (average age 72.1 years; 38% women) who underwent LAA ligation with the Lariat ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--SentreHEART, Inc., the manufacturer of the LARIAT Suture Delivery Device, today announced that it has received approval for an Investigational Device Exemption ...
VANCOUVER, British Columbia--(BUSINESS WIRE)--Aegis Medical Innovations Inc. (Aegis) today announced that it has received Investigational Device Exemption approval from the U.S. FDA to initiate a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results